WPD Pharmaceuticals Inc
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
WPD Pharmaceuticals Inc (WPDPF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.051x
Based on the latest financial reports, WPD Pharmaceuticals Inc (WPDPF) has a cash flow conversion efficiency ratio of 0.051x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-31.58K) by net assets ($-622.29K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
WPD Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2007–2023)
This chart illustrates how WPD Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
WPD Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of WPD Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tedea Technological Development and Automation Ltd
TA:TEDE
|
-0.890x |
|
Graycliff Exploration Limited
PINK:GRYCF
|
0.003x |
|
PCT Ltd
PINK:PCTL
|
0.158x |
|
ISCJ11
SA:ISCJ11
|
N/A |
|
DAIWA SEC GRP - Dusseldorf Stock Exchang
DU:DSE
|
N/A |
|
KEPPEL (KEP1.SG)
STU:KEP1
|
-0.047x |
|
HARMONIC (HMC.SG)
STU:HMC
|
0.020x |
|
BURFORD CAP -NPV-
BE:9BF
|
N/A |
Annual Cash Flow Conversion Efficiency for WPD Pharmaceuticals Inc (2007–2023)
The table below shows the annual cash flow conversion efficiency of WPD Pharmaceuticals Inc from 2007 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-555.96K | $-205.10K | 0.369x | -94.85% |
| 2022-12-31 | $-478.79K | $-3.43 Million | 7.162x | +1856.73% |
| 2021-12-31 | $-4.06 Million | $-1.49 Million | 0.366x | +129.35% |
| 2020-12-31 | $1.11 Million | $-1.38 Million | -1.247x | -2248.01% |
| 2019-12-31 | $3.21 Million | $-170.40K | -0.053x | +93.30% |
| 2018-12-31 | $973.92K | $-772.29K | -0.793x | +66.71% |
| 2017-12-31 | $311.20K | $-741.37K | -2.382x | -931.16% |
| 2016-12-31 | $-253.41K | $-72.63K | 0.287x | +14590.76% |
| 2015-12-31 | $-55.87K | $-109.00 | 0.002x | -99.70% |
| 2014-12-31 | $-33.80K | $-22.05K | 0.652x | -99.08% |
| 2013-12-31 | $-1.72K | $-122.18K | 70.992x | +8099.73% |
| 2012-12-31 | $115.00K | $-102.06K | -0.887x | -36.35% |
| 2011-12-31 | $219.93K | $-143.14K | -0.651x | -45.94% |
| 2010-12-31 | $457.45K | $-204.02K | -0.446x | -10.15% |
| 2009-12-31 | $620.04K | $-251.04K | -0.405x | -173.75% |
| 2008-12-31 | $682.33K | $-100.92K | -0.148x | -31661.51% |
| 2007-12-31 | $453.12K | $-211.00 | 0.000x | -- |